Discussion Topic: Arrhythmic Prognosis According to Left Ventricular Systolic Dysfunction Severity in Cardiac Sarcoidosis
William H. Sauer, MD, FHRS, CCDS, Brigham and Women’s Hospital is joined by Edoardo Bressi, MD Queen Elizabeth Hospital – University Hospitals Birmingham, and Jordana Kron, MD Virginia Commonwealth University to discuss the current guidelines that present varying classes of recommendations for implantable cardioverter-defibrillator (ICD) utilization in patients with cardiac sarcoidosis (CS) and left ventricular ejection fraction (LVEF) <50%. This podcast episode explores a manuscript describing outcomes in these patients.
Host: William H. Sauer, MD, FHRS, CCDS
Guests: Jordana Kron, MD and Edoardo Bressi, MD
Speaker and Article Information: Download
Topic
- The Lead
Resource Type
- Podcasts
Related Resources
The Lead
Podcasts
The Lead Episode 131: A Discussion of Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation: The DECAF Randomized Clinical Trial (Japanese Language Episode)
January 8, 2026
The Lead
Podcasts
The Lead Episode 131: A Discussion of Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation: The DECAF Randomized Clinical Trial (English Language Episode)
January 8, 2026
HRX Next
Podcasts
HRX NeXt Ep. 5 – A Conversation About What AI is and Why Clinicians Should Care
January 7, 2026